PPARGC1A and fatty liver disease: Peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α), AMP-activated protein kinase (AMPK), and peroxisome proliferator-activated receptor α (PPARα) activation play roles in suppressing hepatic steatosis through multiple pathways [23–26].